KEY FACTS
Dr Mark Kotter and Dr Benjamin Davies, world-leading researchers into the causes and treatments of Degenerative Cervical Myelopathy (DCM), answer frequently asked questions from people affected by myelopathy.
References
- Global Burden of Disease 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 The Lancet: Neurology 2019;18(1):56-87
- Davies BM, Phillips R, Clarke D, Furlan JC, Harrop JS, Demetriades A, Milligan J, Witiw CD, Vaccaro A, Kurpad S, Aarabi B, Fehlings MG, Guest J, Wilson J, Kwon B, Rahimi-Movaghar V and Kotter MRN Establishing the socio-economic impact of Degenerative Cervical Myelopathy (DCM) is fundamental to improving outcomes [AO Spine RECODE-DCM Research Priority Number 8]. Global Spine Journal 12 (1 suppl): 122S-129S